Question · asked by 1 review
NORADRENERGIC DRUGS vs DOPAMINERGIC DRUGS: Secondary outcome: acceptability of treatment
- Population
- patients with antipsychotic‐induced tardive dyskinesia
- Intervention
- NORADRENERGIC DRUGS
- Comparison
- DOPAMINERGIC DRUGS
- Outcome
- Secondary outcome: acceptability of treatment
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
NORADRENERGIC DRUGS vs DOPAMINERGIC DRUGS Acceptability of treatment: Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia (2018) · Cochrane Headline outcomes only | no estimate extracted | 0 studies · 0 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- NORADRENERGIC DRUGS vs placebo · patients with antipsychotic‐induced tardive dyskinesia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.